Select Language
IL-23 R/IL-12 R beta 1
IL-23 R/IL-12 R beta 1 Product List
- Product Category
Cell (1)
- Product Status
Launched (1)
- Species
Human (1)
- Tag
- (1)
- Conjugate
- (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
CHEK-ATF166 |  Human | HEK293 | Human IL-23 R/IL-12 R beta 1(Luc) HEK293 Reporter Cell |  |
Total: 1
- 1
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Octahydroaminoacridine succinate | 华洋-001 | Phase 3 Clinical | Changchun Huayang High-Tech Co Ltd, Jiangsu Sheneryang High-Tech Co Ltd | Alzheimer Disease | Details |
| Donepezil/Solifenacin | CPC-201 | Phase 3 Clinical | Cipla Inc, Allergan Plc | Urologic Diseases; Alzheimer Disease; Dementia | Details |
| Botulinum toxin (CKD Bio) | CKDB-501B; CKDB-501-B; CKDB-501A; CKDB-501-A; CKDB-501 | Phase 3 Clinical | CKD Bio Corp | Nasolabial fold wrinkles; Upper and lower limb spasticity | Details |
| BR-4001 | BNT-002; BR-4001 | Phase 3 Clinical | Boryung Pharmaceutical Co Ltd | Alzheimer Disease | Details |
| Botulinum toxin E | EB-001; EB-001A; EB-001T; AGN-151586; BoNT/E; BoNTE | Phase 3 Clinical | Bonti Inc | Nasolabial fold wrinkles; Musculoskeletal Pain | Details |
| Blarcamesine/Donepezil Hydrochloride | Phase 2 Clinical | Anavex Life Sciences Corp | Alzheimer Disease | Details | |
| Ondansetron Hydrochloride/Pyridostigmine Bromide | GTB-004 | Phase 2 Clinical | Gt Biopharma Inc | Myasthenia Gravis | Details |
| Pregnenolone | NBI-113 | Phase 2 Clinical | Neurocrine Biosciences Inc | Schizophrenia; Autism Spectrum Disorder; Menopausal symptoms; Depressive Disorder, Major; Depression; Anxiety; Autistic Disorder; Alcoholism; Stress Disorders, Post-Traumatic; Cocaine-Related Disorders; Low Back Pain | Details |
| Fluoropezil | DC-20; DC-511020 | Phase 2 Clinical | Jiangsu Kanion Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences | Alzheimer Disease | Details |
| Pyridostigmine | K-127 | Phase 2 Clinical | Kashiv BioSciences LLC | Musculoskeletal Diseases; Blepharoptosis; Urination Disorders; Fatigue Syndrome, Chronic | Details |
| Huperizine-A (Biscayne Pharmaceuticals) | INS-001; BIS-001-ER; XEL-001-HG; XEL-001-HP; Hup-A; BIS-001 | Phase 2 Clinical | Harvard University | Seizures; Epilepsy, Complex Partial | Details |
| EX-039 | EX-039 | Phase 2 Clinical | Excelsior Corp | Alzheimer Disease | Details |
| donepezil (Vyant Bio) | VYNT-0126 | Phase 2 Clinical | Vyant Bio Inc | Rett Syndrome | Details |
| YIV-906 | PHY-906; KD-018 | Phase 2 Clinical | Phytoceutica Inc | Liver Neoplasms; Rectal Neoplasms; Pancreatic Neoplasms; Diarrhea; Hepatitis B; Colorectal Neoplasms; Carcinoma, Hepatocellular | Details |
| AD-35 | AD-35 | Phase 2 Clinical | Zhejiang Hisun Pharmaceutical Co Ltd | Alzheimer Disease | Details |
| Edrophonium Chloride | Phase 1 Clinical | Teligent | Myasthenia Gravis | Details | |
| 18F-flubatine | 18F-flubatine; norchloro-fluoroepibatidine-[18F]; flubatine-[18F]; Fluorine-18-flubatine | Phase 1 Clinical | Helmholtz-Zentrum Dresden-Rossendorf | Alzheimer Disease | Details |
| Donepezil Hydrochloride/Mefloquine Hydrochloride | THN-201 | Phase 1 Clinical | Theranexus | Cognitive Dysfunction; Alzheimer Disease | Details |
| Mecripyrine Hydrochloride | SCR-1693; Y-1A; Y-1 | Phase 1 Clinical | Jiangsu Simcere Pharmaceutical Co Ltd, Yantai Yene Pharma Co Ltd, NeuroDawn Pharmaceutical Co Ltd | Brain Neoplasms; Alzheimer Disease | Details |
| Methanesulfonyl fluoride | SNX-001 | Phase 1 Clinical | Senexta | Alzheimer Disease | Details |
| Galantamine/Metformin | RJx-01 | Phase 1 Clinical | Rejuvenate Biomed NV | Muscular Atrophy | Details |
| Donepezil transdermal patch（Dong-A ST） | DA-5207 | Phase 1 Clinical | Dong-A ST Co Ltd | Details | |
| HHT-201 | HHT-201 | Phase 1 Clinical | Zhejiang Huahai Pharmaceutical Co Ltd | Hypertension; Alzheimer Disease | Details |
Marketed Drug Information
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Galantamine Hydrobromide | GP-37267; R-113675 | Approved | AverTox, Nivalin, Reminyl, Razadyne, Reminyl XL | Mainland China | Alzheimer Disease | null | 1981-01-01 | Dementia; Mental Disorders; Fasting; Subarachnoid Hemorrhage; Frontotemporal Dementia; Stress Disorders, Traumatic, Acute; Dementia, Vascular; Cognition Disorders; Cocaine-Related Disorders; Obesity; Nervous System Diseases; Lewy Body Disease; Schizophrenia; Alzheimer Disease; Cognitive Dysfunction; Tobacco Use Disorder; AIDS Dementia Complex; Vascular Diseases; Memory; Autistic Disorder; Stroke; Insulin Resistance; Brain Diseases | Details | |
| Neostigmine Bromide | Approved | Prostigmin | Mainland China | Myasthenia Gravis; Flatulence; Urinary Retention | Shanghai Sine Pharmaceutical Laboratories Co Ltd | 1995-01-01 | Myasthenia Gravis; Headache; Flatulence; Urinary Retention | Details | ||
| Metrifonate | Bay-a-9826; Bayer-L-1359 | Approved | ProMem, Memobay, Bilarcil | Schistosomiasis | Details | |||||
| Rivastigmine Tartrate | SDZ-212-713; SDZ 212713; SDZ-ENA-713; ONO-2540; ENA-713; ENA-713D | Approved | Novartis Pharma Ag | Exelon TDS, Rivastach, Exelon MR, Prometax, Exelon, 艾斯能 | EU | Parkinson Disease; Dementia; Alzheimer Disease | Novartis Europharm Ltd | 1998-05-11 | Substance-Related Disorders; Brain Injuries, Traumatic; Down Syndrome; Delirium; Neurobehavioral Manifestations; Alzheimer Disease; Dementia; Parkinson Disease; Cocaine-Related Disorders; Dementia, Vascular; Cognition Disorders; Anticholinergic Syndrome | Details |
| Pyridostigmine Bromide | Ro-1-5130 | Approved | Valeant | Regonol, Mestinon | United States | Lambert-Eaton Myasthenic Syndrome | Bausch & Lomb (Singapore) Pvi Ltd | 1955-04-06 | Dyskinesias; HIV Seropositivity; Immunologic Deficiency Syndromes; Hypotension, Orthostatic; Fibromyalgia; Diabetes Mellitus; T-Lymphocytopenia, Idiopathic CD4-Positive; Fatigue Syndrome, Chronic; Parkinson Disease; Glycogen Storage Disease Type II; Constipation; Poisoning; Prostatic Neoplasms, Castration-Resistant; Coronavirus Disease 2019 (COVID-19); Postural Orthostatic Tachycardia Syndrome; Lambert-Eaton Myasthenic Syndrome; Heart Failure; Myasthenia Gravis; Primary Dysautonomias; HIV Infections | Details |
| Dimebolin hydrochloride | BRN-0622478; PF-01913539; DMB-I | Approved | Bigespas Ltd | Dimebon | Russian Federation | Rhinitis, Allergic; Dermatitis, Atopic; Hypersensitivity | null | 1983-01-01 | Liver Failure; Huntington Disease; Rhinitis, Allergic; Alzheimer Disease; Dementia; Dermatitis, Atopic; Hypersensitivity | Details |
| Donepezil Hydrochloride | DKF-310; BNAG; E-2020; E-2022; (±)-E-2020; IVL-3003; GB-5001; HZ007 | Approved | Eisai Co Ltd | Memac, Eranz, Memorit, Aricept Evess, Aricept, Aricept ODT, Aricept D, 安理申, ADLARITY | United States | Alzheimer Disease | Eisai Inc | 1996-11-25 | Cognitive Dysfunction; Radiation Injuries; Aphasia; Hearing Loss, Sensorineural; Fragile X Syndrome; Brain Neoplasms; Breast Neoplasms; Alzheimer Disease; Parkinson Disease; Alcoholism; Multiple Sclerosis; Dementia; Lewy Body Disease; Psychological Distress; Wounds and Injuries; Dementia, Vascular; Memory Disorders; Anorexia Nervosa; Cognition Disorders; Subarachnoid Hemorrhage; Attention Deficit Disorder with Hyperactivity; Migraine Disorders; Supranuclear Palsy, Progressive; Brain Ischemia; Down Syndrome; Depression; Autism Spectrum Disorder; Neurologic Manifestations; Osteoporosis; Diabetes Mellitus, Type 2; Visual Perception; Neoplasms; Sleep Wake Disorders; Fatigue; Anxiety Disorders; Delirium; Stroke; Neurotoxicity Syndromes; Central Nervous System Neoplasms; Autistic Disorder | Details |
| Memantine Hydrochloride/Donepezil Hydrochloride | ADS-8704; D-797/D-324; CKD 355; BPS-034; BPDO-1603; MDX-8704 | Approved | Allergan Plc | Arimenda, Namzaric | United States | Alzheimer Disease | Abbvie Inc | 2014-12-23 | Alzheimer Disease | Details |
| Huperzine A | SPN-817 | Approved | Chinese Academy Of Sciences, Mayo Clinic | 哈伯因, 双益平 | Mainland China | Alzheimer Disease | Henan Taloph Pharmaceutical Stock Co Ltd | 1994-01-01 | Schizophrenia; Brain Injuries, Traumatic; Seizures; Alzheimer Disease; Epilepsy; Learning Disabilities; Memory Disorders | Details |
| Distigmine Bromide | BC-51 | Approved | Torii Pharmaceutical Co Ltd | Ubretid | Japan | Glaucoma; Cystitis; Myasthenia Gravis; Strabismus | Torii Pharmaceutical Co Ltd | 1967-09-05 | Myasthenia Gravis; Cystitis; Glaucoma; Strabismus | Details |
| Pralidoxime Chloride | 2-PAM-chloride | Approved | Baxter International Inc | Protopam chloride | United States | Poisoning | Baxter Healthcare Corp | 1964-03-11 | Poisoning | Details |
| Pralidoxime Iodide | 2-PAMI; NSC-7760; 2-PAM Iodide | Approved | Japan | Poisoning | Sumitomo Dainippon | 1958-05-01 | Poisoning | Details | ||
| Eserine Salicylate | Approved | Synapton SR, Xalieve, Antilirium | Insulin Resistance; Pain, Postoperative; Psychotic Disorders; Glaucoma | Details | ||||||
| Neostigmine methylsulfate | Approved | Bloxiverz, Intrastigmina, Juvastigmin, Stiglyn, Metastigmin | Japan | Myasthenia Gravis; Muscle Hypotonia | kyowayakuhin Co | 1936-10-01 | Myasthenia Gravis; Flatulence; Urinary Retention; Reversal of Neuromuscular Blockade; Muscle Hypotonia | Details | ||
| Naphazoline Hydrochloride/Neostigmine methylsulfate/Glycyrrhizinate dipotassium/Chlorphenamine Maleate/Aspartic Acid/Vitamin B6 | Approved | 新乐敦 | Details | |||||||
| Dextrose/Sodium Chloride/Potassium Chloride/Floxacillin sodium | Approved | Details | ||||||||
| Dextrose/Sodium Chloride/Potassium Chloride/Anthralin | Approved | Details | ||||||||
| Dextrose/Sodium Chloride/Potassium Chloride/Pralidoxime Chloride | Approved | Details | ||||||||
| Pralidoxime Chloride/Benactyzine Hydrochloride/Atropine Sulfate | Approved | Poisoning | Details | |||||||
| Naphazoline Hydrochloride/Neostigmine methylsulfate | Approved | Details | ||||||||
| Dihydrogalanthamine Hydrobromide | Approved | Mainland China | Hemiplegia; Sciatica | null | 1982-01-01 | Hemiplegia; Sciatica | Details | |||
| Securinine Nitrate | Approved | Poliomyelitis; Facial Paralysis | Details | |||||||
| Rivastigmine | Approved | Novartis Pharma Ag | Parkinson Disease; Alzheimer Disease | Details | ||||||
| Glycopyrronium bromide/Neostigmine metilsulfate | Approved | Sintetica Gmbh | Novistig | Sintetica Gmbh | 2020-07-29 | Drug Overdose; Reversal of Neuromuscular Blockade; Muscle Hypotonia; Neuromuscular Diseases | Details | |||
| Benzgalantamine | Alpha 1062; ALPHA-1062 Intranasal; GLN-1062; ALPHA-1062; ALPHA-1062IN | Approved | Galantos Pharma GmbH | Zunveyl | United States | Alzheimer Disease | Alpha Cognition Inc | 2024-07-26 | Brain Injuries, Traumatic; Cognitive Dysfunction; Alzheimer Disease | Details |
| Atropine/Pralidoxime Chloride | Approved | Meridian Medical Technologies Inc | DUODOTE | United States | Poisoning; Organophosphate Poisoning | Meridian Medical Technologies LLC | 2002-01-17 | Drug-Related Side Effects and Adverse Reactions; Organophosphate Poisoning; Poisoning; Drug intoxications | Details | |
| Acotiamide Hydrochloride Hydrate | Z-338; YM-443 | Approved | Zeria | Acofide | Japan | Dyspepsia | null | 2013-03-25 | Dyspepsia; Nausea | Details |
- Product List
- Marketed Drug Information
- Clinical Drug Information
Share to:
Online Message
Contact Us
BettinastraBe 30, 60325 Frankfurt am Main